medigraphic.com
ISSN 1816-8450 (Print)

2016, Number 2

<< Back Next >>

Geroinfo 2016; 11 (2)

Deterioro cognitivo leve (DCL) y comorbilidad

Cascudo BN, Varona GDG, Brenes HL

Language: Spanish
References: 42
Page: 1-15
PDF size: 173.06 Kb.


ABSTRACT

Objectives: To specify the importance of investigating the mild cognitive impairment, prevalencia, concepts, diagnostic classifications, factors of risk and their relationship with the multimorbidity/comorbidity.
Development: These investigations will be valued, concepts, approaches, controversies and the important relationship with the comorbidity.
Conclusions: Importance of enlarging the investigations in this given field the complexity in their diagnosis for their heterogenic dad and uncertainty for their value predictive. The importance of the early detection of the decline cognitive is vital due to the implications partner-singular, socioeconomic and family and its relationship with the comorbidity that will allow to continue perfecting the diagnostic tools of this entity.


REFERENCES

  1. Statistical Yearbook, MINSAP, Cuba. Ministry o f Public Health (2009). Disponible en: http://files.sld.cu/dne/files/2010/04/anuario- 2009e3.pdf

  2. Petersen R, Stevens JC, Ganguli M, Tanaglos E, et al. Practice parameter: mild cognitive impairment (an evidence-based review).Neurology. 2001; 56: 1133-42.

  3. Petersen R.C. Clinical practice. Mild cognitive impairment. N Engl J Med. 2011 Jun 9; 364(23):2227-34.

  4. GedaY, Topazian H, Lewis R, Roberts R, Knopman D, Pankratz SH, Christianson T, et al. Engaging in Cognitive Activities, Aging, and Mild Cognitive Impairment: A Population-Based Study. The Journal of Neuropsychiatry and Clinical Neurosciences 2011; 23:149-54.

  5. Rosselli M, Ardila A. Deterioro Cognitivo Leve: Definición y Clasificación. Revista Neuropsicología, Neuropsiquiatría y Neurociencias, Abril 2012, Vol.12, Nº1, pp. 151-162.

  6. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging- Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 270-9.

  7. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR ,Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging- Alzheimer’s

  8. Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 263-9.

  9. Petersen R.C,Negash S. Mild cognitive impairment: An overview. CNS Spectr. 2008; 13(1):45-53.

  10. Petersen R.C, Roberts R.O,Knopman D.S. Mild cognitive impairment: Tenyears later. Arch Neurol. 2009; 66(12) 1447-55.

  11. Allegri RF, Laurent B, Thomas-Anterion C, Serrano CM. La memoria en el envejecimiento, el deterioro cognitivo y la enfermedad de Alzheimer. In

  12. Mangone C, Allegri RF, Arizaga RL, Ollari JA, eds. Demencia, enfoque nterdisciplinario. Buenos Aires: Polemos. 2005: 82.

  13. Ganguli M, Snitz B.E, Saxton J.A, Chang C.C, Lee C.W, Vander B, Hughes T.F, Loewenstein D.A, Unverzagt F.W, Petersen R.C. Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol. 2011 Jun; 68(6):761-7.

  14. Mías C, Sassi M, Masih ME, Querejeta A, Krawchik R. Deterioro cognitivo leve: estudio de prevalencia y factores sociodemográficos en la ciudad de Córdoba, Argentina. RevNeurol 2007; 44 (12): 733-738.

  15. Llibre Guerra JC, Guerra M, Perera E. Comportamiento de las enfermedades crónicas no transmisibles en adultos mayores. RevCubMed Gen Integr 2008; 24 (4).

  16. Demencia: Una prioridad de Salud Pública: Ginebra, abril-2012. Disponible en http://www.alz.co.uk/WHO-dementia-report.

  17. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 2010; 9: 1118-27.

  18. Mora-Simon S, Garcia-Garcia R, Perea-Bartolome MV, LaderaFernandez V, Unzueta-Arce J, Patino-Alonso MC, et al. Deterioro cognitivo leve: detección temprana y nuevas perspectivas. RevNeurol 2012; 54: 303-10.

  19. Roberts R, Knopman DS. Classification and Epidemiology of MCI. ClinGeriatr Med. 2013 November; 29(4): doi:10.1016/j.cger.2013.07.003.

  20. American physiquiatric Association: diagnostic and Statistical Manual of Mental Disorders, 4ed. AMA, Washintong DC, 1994.

  21. Abizanda Soler P et al. Evaluacion de la comorbilidad en la poblacion anciana: utilidad y validez de los instrumentos de medida. Rev EspGeriatrGerontol. 2010;45(4):219–28.

  22. Lopez OL. Mild Cognitive impairment Continuum (MinneapMinn) 2013;19(2):411-424

  23. Peterson JC, Burnes DP, Caccamise PL, Mason A, Henderson CR Jr, Wells MT, et al. Financial explotation of older adults: a population-based prevalence study. J Gen Intern Med. 2014 (12):1615–23.

  24. Global population ageing: peril or promise. Geneva: World Economic Forum; 2011(http://www3.weforum.org/docs/WEF_GAC_GlobalPopulationAgeing_R eport_2012.pdf, accessed 20 July 2015.

  25. Rosenfeld O. Social and affordable housing finance – current trends and challenges in countries with mature social housing sector. Geneva: United Nations Economic Commission for Europe; 2014. Disponible en: http://www.unece.org/fileadmin/DAM/hlm/prgm/hmm/social%20housing/gen eva2014/1.05.rosenfeld.pdf, accessed 10 July 2015.

  26. Corinne E Fischer, Depeng Jiang, Tom A Schweizer: Determining the association of medical comorbidity with subjective and objective cognitive performance in an inner city memory disorders clinic: a retrospective chart review BMC Geriatrics. 2010,10:89.

  27. Bunn F, Burn AM, Goodman C, Rait G, Norton S, Robinson L, Schoeman J,Brayne C: Comorbidity and dementia: a scoping review of the literature BMC Medicine 2014; 12:192.

  28. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.Lancet 2012;380:37-43.

  29. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann intern med 1992;117(12):1003-9.

  30. Roca-Socarras A, Henriette K. Comportamiento de la cognición y comorbilidad en pacientes con infarto cerebral hospitalizados. Seychelles 2010-2011. Revista Finlay [revista en Internet]. 2012 [citado 2016 Jun 3]; 2(3): Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/10

  31. Vassilaki M, Aakre J, Cha R, Kremers W, St. Sauver J, Mielke M, et al. Multimorbidity and Risk of Mild Cognitive Impairment. JAGS 63:1783–1790, 2015.

  32. Caracciolo B, Gatz M, Xu W, Marengoni A,.Pedersen N, Fratiglioni L. Relation of multimorbidity to subjective and objective cognitive impairment: a population-based twin study J Alzheimers Dis. 2013; 36(2): 275–84.

  33. Llibre JJ, Valhuerdi A, Calvo M, García R, Guerra M, Laucerique T, López AM, Llibre JC, Noriega L, Sánchez I et al. Dementia and Other Chronic Diseases in Older Adults in Havana and Matanzas: The 10/66 Study in Cuba. MEDICC Review, October. 2011; (13).4

  34. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4(11):752-9.

  35. Marshall RS, Lazar RM. Pumps, aqueducts, and drought management: vascular physiology in vascular cognitive impairment. Stroke. 2011;42(1):221-6.

  36. Snowdon DA, Greiner LH, Mortimer JA, Riley KP,Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277(10):813-7.

  37. Leggett A, Zarit S, ChuongH, Nguyen HT. Correlates of Cognitive Impairment in Older Vietnamese. AAging Ment Health. 2013; 17(8): 915– 923. doi:10.1080/13607863.2013.799116.

  38. Minh, L. Vietnam: Average life span increases to 73. 2011. Retrieved from http://english.vietnamnet.vn/en/society/16050/vietnam--average-lifespanincreases- to-73.html.

  39. Petersen R, Caracciolo B, Brayn C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014 March; 275(3): 214–228. doi:10.1111/joim.12190.

  40. Demey I, Allegri RF. Intervenciones Terapéuticas Cognitivas en el Deterioro Cognitivo Leve.Vertex. 2010 Jul-Aug; 21(92):253-9.

  41. Tang, Brayne, Albanese, Stephan. Mild cognitive impairment definitions: more evolution than revolution. Neurodegener. Dis. Manag. 2015; 5(1):11– 17.

  42. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999; 56:303-308.




2020     |     www.medigraphic.com